BioMarin Pharmaceutical: $720 Million Public Offering of Common Stock

BioMarin Pharmaceutical Inc., developer of biopharmaceuticals for diseases and medical assistance, in its $720 million public offering of common stock.
Related Contacts
Chadwick Mills Partner, San Francisco
Related Practices & Industries

Life Sciences Capital Markets